| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/21/2005 | EP0712303B1 Skin patches comprising testosterone and optionally estrogen |
| 09/21/2005 | CN1671856A Novel physiologically active substances |
| 09/21/2005 | CN1671837A Neutralizing human anti-IGFR antibody |
| 09/21/2005 | CN1671744A Low molecular weight oversulfated polysaccharide |
| 09/21/2005 | CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair |
| 09/21/2005 | CN1671730A Oligonucleotide-containing pharmacological compositions and their use |
| 09/21/2005 | CN1671729A Control sequences of the human Corin gene |
| 09/21/2005 | CN1671716A Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/21/2005 | CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/21/2005 | CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/21/2005 | CN1671711A Calcitonin gene related peptide receptor antagonists |
| 09/21/2005 | CN1671708A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 09/21/2005 | CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof |
| 09/21/2005 | CN1671700A Substituted alkylamine derivatives and methods of use |
| 09/21/2005 | CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors |
| 09/21/2005 | CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 09/21/2005 | CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 09/21/2005 | CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 09/21/2005 | CN1671650A Crystalline beta2 adrenergic receptor agonist |
| 09/21/2005 | CN1671643A Bipolar trans carotenoid salts and their uses |
| 09/21/2005 | CN1671639A Novel biphenyl and biphenyl-like cannabinoids |
| 09/21/2005 | CN1671421A Inclusion complexes of rosiglitazone |
| 09/21/2005 | CN1671399A Myocardial perfusion imaging using A2A receptor agonists |
| 09/21/2005 | CN1671392A Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 09/21/2005 | CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/21/2005 | CN1671376A Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent |
| 09/21/2005 | CN1671372A Food improving blood flow |
| 09/21/2005 | CN1670026A Lotus plumule alkaloid extract and its preparation process and use in preparation of drugs for cardiovascular and cerebrovascular diseases |
| 09/21/2005 | CN1669578A Injection for treating cardiovascular and cerebrovascular diseases and process for preparing same |
| 09/21/2005 | CN1669575A Novel drug for treating cardiovascular and cerebrovascular diseases and process for preparing same |
| 09/21/2005 | CN1669573A Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 09/21/2005 | CN1669566A Preparation method of Astragaloside material medicine, the material medicine and preparation |
| 09/21/2005 | CN1669564A Traditional Chinese medicine preparation for treating cranial vascular diseases, its preparation method and application |
| 09/21/2005 | CN1669556A Breviscapine preparation and preparing process thereof |
| 09/21/2005 | CN1669552A Ethylamine thiourea injection and preparation method thereof |
| 09/21/2005 | CN1220060C Process for screening active component from plant extract |
| 09/21/2005 | CN1219940C Toilet paper for anal fistula disease |
| 09/21/2005 | CN1219794C Platelet glucoprotein receptor inhibitor, medicinal composition containing same and use thereof |
| 09/21/2005 | CN1219763C Substituted indole mannich bases |
| 09/21/2005 | CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 09/21/2005 | CN1219748C Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride |
| 09/21/2005 | CN1219556C The use of 4-H-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 09/21/2005 | CN1219523C Buccal lozenge of notoginseng flower |
| 09/21/2005 | CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process |
| 09/20/2005 | US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product |
| 09/20/2005 | US6946492 Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity |
| 09/20/2005 | US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/20/2005 | US6946489 Substituted biphenyl derivatives |
| 09/20/2005 | US6946483 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same |
| 09/20/2005 | US6946478 Compounds |
| 09/20/2005 | US6946467 Serine protease inhibitors |
| 09/20/2005 | US6946449 5*-sulfoxy-adensoine derivatives used to treat tachycardia and atrial flutter, angina, and myocardial infarction |
| 09/20/2005 | US6946445 peptide antagonists of CXC chemokine receptor 4, CXCR4; cancer and autoimmune diseases; protein that comprises an N-terminal sequence of KGVSLSYR (SEQ ID NO: 3); stromal cell derived factor one (SDF-1 ligand |
| 09/20/2005 | US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance |
| 09/20/2005 | US6946441 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 09/20/2005 | US6946438 focal cerebral ischemic infarction; plasmin, mini-plasmin (lacking the first four kringles), and micro-plasmin (lacking all five kringles) |
| 09/20/2005 | US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/20/2005 | US6945247 Method of treating cardio pulmonary diseases with no group compounds |
| 09/20/2005 | CA2231535C Imidazole derivatives having affinity for alpha2 receptors activity |
| 09/20/2005 | CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same |
| 09/20/2005 | CA2170606C Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 09/15/2005 | WO2005085846A1 Diagnostic for ischemic heart disease risk group |
| 09/15/2005 | WO2005085267A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 09/15/2005 | WO2005085265A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 09/15/2005 | WO2005085264A1 Sulfated oligosaccharide derivatives |
| 09/15/2005 | WO2005085237A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 09/15/2005 | WO2005085228A1 Cycloalkanopyridine derivative |
| 09/15/2005 | WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative |
| 09/15/2005 | WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient |
| 09/15/2005 | WO2005085201A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein |
| 09/15/2005 | WO2005085200A1 Pyridone derivative |
| 09/15/2005 | WO2005085195A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 09/15/2005 | WO2005084702A1 Agent for preventing and treating organ fibrosis |
| 09/15/2005 | WO2005084697A1 Regulator for adiponectin receptor expression |
| 09/15/2005 | WO2005084679A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 09/15/2005 | WO2005084668A1 Medicine for prevention and/or treatment of ischemic circulatory disease |
| 09/15/2005 | WO2005084665A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof |
| 09/15/2005 | WO2004096792A3 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050204412 Artery- and vein-specific proteins and uses therefor |
| 09/15/2005 | US20050203295 NO donor has a nitroso group attached to a tertiary carbon; vascular relaxants, nonsteroidal anti-inflammatory drug; water soluble; potentiated by adding glutathione, use low dosage |
| 09/15/2005 | US20050203284 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 09/15/2005 | US20050203165 Perfectly reproducible crystalline form that especially exhibits valuable characteristics for formulation of inhibitors of angiotensin I converting enzyme; preparation from a solution of the salt in CH2Cl2 or ethyl acetate; treating cardiovascular disease |
| 09/15/2005 | US20050203153 Drugs with carriers as prodrugs for anticancer agents |
| 09/15/2005 | US20050203127 2-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 09/15/2005 | US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia |
| 09/15/2005 | US20050203125 Treating pseudobulbar affect or emotional lability; nervous system, brain, and neurodegenerative disorders; analgesics; neuropathic pain; dextromethorphan hydrobromide and quinidine sulfate |
| 09/15/2005 | US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular |
| 09/15/2005 | US20050203112 Bicyclic amides |
| 09/15/2005 | US20050203109 Novel Compounds |
| 09/15/2005 | US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/15/2005 | US20050203079 Serotonin (5-HT) 2c receptors; antidepressants, anxiolytic agents; 3-(3,4-Dichloro-phenyl)-3-hydroxy-1-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-pyrrolidin-2-one for example |
| 09/15/2005 | US20050203073 Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 09/15/2005 | US20050203066 Preventing mitochondrial respiratory chain dysfunction in mammal by administering a pyrimidine nucleotide precursor and pyruvic acid, ester or salt; neurodegenerative, muscular, urogenital, or developmental disorders; autism, neuropathic pain, headaches; anticarcinogenic agents; cognition activators |
| 09/15/2005 | US20050203065 Use of A2b adenosine receptor antagonists such as 3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid (BG 9928) |
| 09/15/2005 | US20050203059 Methods and compositions for treatment of ischemia |
| 09/15/2005 | US20050203021 Identifying prorenin modulators for treatment of cardiovascular and organ hypertrophy; enzyme inhibitors; mimetics; blood pressure; arterial thickening |
| 09/15/2005 | US20050203003 Contulakin-G, analogs thereof and uses therefor |
| 09/15/2005 | US20050202548 Mammalian enzymatic polypeptide for use as tool in designing drugs which prevent and treat hypercholesterolemia, hyperlipemia, arteriosclerosis, parasitic infection, cell proliferative and vascular diseases |
| 09/15/2005 | US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide |